Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 7Observational 3

Sponsor

Cancer Type

Other 3

Conditions

Obesity 112Neoplasms 43Sexual Dysfunction, Physiological 31Polycystic Ovary Syndrome 27Overweight 18Breast Neoplasms 18Diabetes Mellitus 16Colorectal Neoplasms 16Dyspnea 14Diabetes Mellitus, Type 2 13Obesity, Morbid 12Mucositis 12Constipation 12Depression 11Prostatic Neoplasms 10Lung Neoplasms 10Hypertension 10Pulmonary Disease, Chronic Obstructive 9Non-alcoholic Fatty Liver Disease 9Metabolic Syndrome 9Insulin Resistance 9Motor Activity 8Cardiovascular Diseases 8Renal Insufficiency, Chronic 7Opioid-Induced Constipation 7Heart Failure 7Asthma 7Sarcopenia 6Rectal Neoplasms 6Multiple Myeloma 6

Interventions

Paclitaxel 1Docetaxel 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Chemotherapy-induced Peripheral Neuropathy × Other × Clear all
NCT05759052 2025-12-24

CIPN-LEA

University Hospital, Clermont-Ferrand

Completed
467 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

NCT06491082 2024-07-08

CIN

Swami Rama Himalayan University

Recruiting
124 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

NCT04393363 2024-01-31

NOVIT1

Aalborg University Hospital

Active not recruiting
20 enrolled
Other

Chemotherapy-induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡